Furthermore, we also provided a prognostic signature to predict prognosis of ccRCC patients and related signal pathways regulated by METTL14 by means of gene set enrichment analysis (GSEA). This evidence concerns the gene METTL14 and nonpapillary renal cell carcinoma.